Status:

COMPLETED

TMS Treatment in Parkinson's Disease With Pain.

Lead Sponsor:

Xuanwu Hospital, Beijing

Conditions:

Transcranial Magnetic Stimulation

Parkinson Disease

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Transcranial magnetic stimulation (TMS) is a procedure that has been shown to improve pain in chronic sufferers. It is a well-tolerated procedure that can be performed on an outpatient basis. It uses ...

Eligibility Criteria

Inclusion

  • Patients with Parkinson's disease diagnosed as "clinically confirmed" or "very likely" according to the 2015 MDS clinical diagnostic criteria;
  • Age ≥ 18 Aged ≤ 80 years old;
  • PD patients with pain, exclude tumors, diabetes, osteoarthritis, rheumatoid rheumatism and other diseases, the use of analgesic drugs is not effective or insignificant.
  • After treatment with anti-Parkinson's disease drug regimen, anti-anxiety and depression, sleep drugs, analgesic drugs, etc. for ≥ 14 days, and the dosage is maintained during the treatment;
  • Ability to follow research plans and visit plans.

Exclusion

  • Secondary Parkinson's syndrome caused by vascular factors, toxins, drugs, etc., or Parkinson's superposition syndrome.
  • PD patients with persistent head tremors.
  • Dementia, simple intelligent state check (mmse) ≤ 24 points.
  • Patients with suicidal tendencies and psychotic symptoms. 5, previously accepted dbs or damage surgery.
  • 6\. Contraindications for TMS (such as history of seizures, pregnant women, installation of pacemakers, metal inclusions in the body, intracranial hypertension, severe bleeding tendency, etc.)

Key Trial Info

Start Date :

May 6 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 30 2020

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT04048265

Start Date

May 6 2019

End Date

January 30 2020

Last Update

April 15 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Neurology Department of Xuanwu Hospital,Capital Medical University

Beijing, Beijing Municipality, China, 100053